1,379 results on '"Kaiser, Laurent"'
Search Results
2. Orthopox viruses: is the threat growing?
3. Prognosis and prediction of antibiotic benefit in adults with clinically diagnosed acute rhinosinusitis: an individual participant data meta-analysis
4. Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection
5. Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species
6. SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses
7. Analysis of global routine immunisation coverage shows disruption and stagnation during the first two-years of the COVID-19 pandemic with tentative recovery in 2022
8. Socioeconomic conditions and children's mental health and quality of life during the COVID-19 pandemic: An intersectional analysis
9. Viremia as a predictor of absence of serious bacterial infection in children with fever without source
10. The Prevalence, Severity, and Impact of Post-COVID Persistent Fatigue, Post-Exertional Malaise, and Chronic Fatigue Syndrome
11. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2
12. Geneticin shows selective antiviral activity against SARS-CoV-2 by interfering with programmed −1 ribosomal frameshifting
13. Characteristics of long-COVID among older adults: a cross-sectional study
14. Impact of interactive computerised decision support for hospital antibiotic use (COMPASS): an open-label, cluster-randomised trial in three Swiss hospitals
15. The present and future of blood virome in allogeneic hematopoietic cell transplant recipients
16. Feasibility of home-based ELISA capillary blood self-testing for anti-SARS-CoV-2 antibodies
17. Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva
18. A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents
19. Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
20. Feasibility, acceptability, and effectiveness of non-pharmaceutical interventions against infectious diseases among crisis-affected populations: a scoping review
21. Clinical sign and biomarker-based algorithm to identify bacterial pneumonia among outpatients with lower respiratory tract infection in Tanzania
22. A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samples
23. Unexpected associations between respiratory viruses and bacteria with Pulmonary Function Testing in children suffering from Cystic Fibrosis (MUCOVIB study)
24. SCANellome V2: Update of the Primate Anellovirus Reference Sequences Database.
25. Novel Use of Capture-Recapture Methods to Estimate Completeness of Contact Tracing during an Ebola Outbreak, Democratic Republic of the Congo, 2018-2020
26. Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial
27. Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland
28. Clinical features of covid-19
29. Covid-19 : a puzzle with many missing pieces
30. Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms
31. Novel SARS-CoV-2 variants: the pandemics within the pandemic
32. Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study
33. How much should we sequence? An analysis of the Swiss SARS-CoV-2 surveillance effort
34. Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
35. Immune escape of Omicron lineages BA.1, BA.2, BA.5.1, BQ.1, XBB.1.5, EG.5.1 and JN.1.1 after vaccination, infection and hybrid immunity
36. S-Gene Target Failure as an Effective Tool for Tracking the Emergence of Dominant SARS-CoV-2 Variants in Switzerland and Liechtenstein, Including Alpha, Delta, and Omicron BA.1, BA.2, and BA.4/BA.5
37. Which trial do we need? Randomized, placebo-controlled trial of antiviral treatment in patients hospitalized for influenza
38. La révolution des médicaments à action prolongée
39. Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy
40. Sensitivity of nasopharyngeal, oropharyngeal, and nasal wash specimens for SARS-CoV-2 detection in the setting of sampling device shortage
41. Outbreak analytics : a developing data science for informing the response to emerging pathogens
42. Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents
43. Influenza-associated aspergillosis in critically-ill patients—a retrospective bicentric cohort study
44. Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation
45. Hepatitis E virus infection epidemiology in allogeneic hematopoietic cell transplant recipients
46. Characteristics of possible mpox reinfection cases: literature review
47. Direct Dengue Virus Genome Sequencing from Antigen NS1 Rapid Diagnostic Tests: A Proof-of-Concept with the Standard Q Dengue Duo Assay
48. Non-Steroidal Estrogens Inhibit Influenza Virus by Interacting with Hemagglutinin and Preventing Viral Fusion
49. Puumala Virus Infection in Family, Switzerland
50. Severe viral respiratory infections in children with IFIH1 loss-of-function mutations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.